Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.optom.2016.06.003 http://scihub22266oqcxt.onion/10.1016/j.optom.2016.06.003 C5484779!5484779!27461520     free     free     free       J+Optom 2017 ; 10 (3): 194-8 Nephropedia Template TP {{tp|p=27461520|t=2017. MyoRing treatment of myopia |pdf=|usr=}}{{27461520}} gab.com Text MyoRing treatment of myopia JO: J Optom http://www.kidney.de/pget.php?&tw=1&pmid=27461520 #FOAvip Introduction: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life. Materials and methods: 19 myopic eyes of 12 patients ranging from ?2.25 to ?16.5 dioptres (D) in sphere and from 0 to ?4 D in cylinder were analyzed. Results: After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from ?10.27 D to ?0.93 D. Efficacy index was 0.76 and safety index was 1.02. Conclusion: MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important. Twit Text FOAVip MyoRing treatment of myopia ????J Optom http://www.kidney.de/pget.php?&tw=1&pmid=27461520 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27461520 #FOAvip English Wikipedia <ref>{{Cite pmid|27461520}}</ref> MyoRing treatment of myopia #MMPMID27461520 Daxer A J Optom 2017[Jul]; 10 (3): 194-8 PMID27461520show ga Introduction: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life. Materials and methods: 19 myopic eyes of 12 patients ranging from ?2.25 to ?16.5 dioptres (D) in sphere and from 0 to ?4 D in cylinder were analyzed. Results: After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from ?10.27 D to ?0.93 D. Efficacy index was 0.76 and safety index was 1.02. Conclusion: MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important. äMyoRing treatment of myopia (epmc).pdf DeepDyve Pubget Overpricing